| 1 |
30651784 | Elevated methylation of cyclin dependent kinase inhibitor 2B contributes to the risk of coronary heart disease in women. | 2019 Jan |
1 |
| 2 |
29070127 | [Inhibitory Effect of Decitabine on Proliferation of MDS-L Cells and Its Mechanism]. | 2017 Oct |
1 |
| 3 |
25652099 | Downregulation of HO-1 promoted apoptosis induced by decitabine via increasing p15INK4B promoter demethylation in myelodysplastic syndrome. | 2015 Apr |
5 |
| 4 |
26317501 | Targeting the Sonic Hedgehog-Gli1 Pathway as a Potential New Therapeutic Strategy for Myelodysplastic Syndromes. | 2015 |
1 |
| 5 |
26782424 | Role of heme oxygenase-1 in demethylating effects on SKM-1 cells induced by decitabine. | 2015 Dec 22 |
3 |
| 6 |
24519046 | [Proliferative and invasive effects of inhibitors of kinase 4(P15(ink4b) and P16(ink4a)/CDKN2) gene activation on RKO human colorectal cancer cells]. | 2014 Jan |
1 |
| 7 |
23683424 | [p15(INK4B) methylation on prognosis and response to decitabine in patients with MDS]. | 2013 Mar |
4 |
| 8 |
22399596 | Antiproliferative and antitumor effects of azacitidine against the human myelodysplastic syndrome cell line SKM-1. | 2012 Mar |
2 |
| 9 |
22654424 | Anti-tumor effect of 5-aza-2'-deoxycytidine by inhibiting telomerase activity in hepatocellular carcinoma cells. | 2012 May 21 |
1 |
| 10 |
21125401 | Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring. | 2011 Jun |
2 |
| 11 |
19881540 | Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition. | 2010 Jan 28 |
4 |
| 12 |
20051228 | CTCF is a DNA methylation-sensitive positive regulator of the INK/ARF locus. | 2010 Feb 5 |
1 |
| 13 |
20190193 | Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML. | 2010 Apr 15 |
2 |
| 14 |
18704418 | Complete cytogenetic remission after decitabine treatment in a patient with secondary AML harbouring high p15INK4b gene methylation and high global DNA methylation. | 2009 Mar |
1 |
| 15 |
18718068 | [Effect of decitabine combined with Trichostatin A on MDS cell line SKM-1 in vitro]. | 2008 Aug |
4 |
| 16 |
17258075 | Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression. | 2007 Feb |
1 |
| 17 |
16292549 | In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studies. | 2005 Dec |
2 |
| 18 |
15015578 | Activation of expression of p15, p73 and E-cadherin in leukemic cells by different concentrations of 5-aza-2'-deoxycytidine (Decitabine). | 2004 Jan-Feb |
3 |
| 19 |
12351408 | Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment. | 2002 Oct 15 |
6 |
| 20 |
12485524 | [The re-expression of p15(INK4B) gene in leukemia cells induced by in vitro DNA methyltransferase and histone deacetylase inhibition]. | 2002 Nov |
2 |
| 21 |
11479232 | Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumors. | 2001 Aug 1 |
2 |
| 22 |
11602627 | Dynamic DNA methylation change in the CpG island region of p15 during human myeloid development. | 2001 Oct |
1 |
| 23 |
8631003 | Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. | 1996 Feb 15 |
1 |